The hospital has always taken the improvement of medical science and technology as the key strategy to promote the sustainable development of the hospital, following the pace of the times and market demand, and actively developing new technologies and efficiency growth points. In recent years, a number of advanced medical technologies and projects focusing on small incision cholecystectomy, cardiovascular and cerebrovascular internal medicine, orthopedic trauma, laparoscopic surgery, and external microwave lithotripsy have become more and more standardized and mature, which has made the hospital's level of medical technology rank among the advanced hospitals of the same level. The small incision cholecystectomy technology, which has been carefully cultivated and created, has attracted a large number of gallstone patients with its advantages of small surgical openings, fast healing, high success rate, low patient pain, low cost, etc., and has carried out more than 10,000 surgeries, with a success rate of nearly 100%. The program has now joined the international collaborative network of minimally invasive gallbladder surgery, won the first prize for scientific and technological progress of China Railway Construction Corporation system, and has become a high-quality brand that demonstrates the hospital's technical strength and enhances the hospital's image, enjoying a good reputation and occupying an important market share in the Taiyuan area as well as inside and outside the province. In recent years, the hospital has also developed and introduced more than 120 new technologies and projects, among which the research and application of multi-functional magnetic water bath therapeutic instrument has won the provincial technology patent, arterial perfusion treatment of middle and advanced malignant tumors, direct suture surgery after common bile duct exploration and stone removal, and the improvement of small-incision cholecystectomy instruments have been awarded the Second Prize of the Scientific and Technological Advancement of the China Railway Construction Corporation, and the research of the pathogenesis law of acute myocardial infarction and the treatment of abdominal snake with anti-thrombolytic enzyme has been awarded the The research on the pathogenesis of acute myocardial infarction and the treatment of abdominal snake antithrombotic enzyme won the second prize of Taiyuan Science and Technology Commission. In addition, the hospital has written more than 2,000 medical papers, of which more than 600 have been published in national journals and more than 800 have been published in provincial and ministerial journals.